发布求助
文献互助 智能选刊 最新文献

Journal of Investigative Dermatology最新文献

筛选
英文 中文
Clinical Snippets 临床片段
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-10-21 DOI: 10.1016/j.jid.2024.09.001
{"title":"Clinical Snippets","authors":"","doi":"10.1016/j.jid.2024.09.001","DOIUrl":"10.1016/j.jid.2024.09.001","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 11","pages":"Page 2337"},"PeriodicalIF":5.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editors' Picks 编辑推荐
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-10-21 DOI: 10.1016/j.jid.2024.08.019
{"title":"Editors' Picks","authors":"","doi":"10.1016/j.jid.2024.08.019","DOIUrl":"10.1016/j.jid.2024.08.019","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 11","pages":"Page 2338"},"PeriodicalIF":5.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subscription Information 订阅信息
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-10-21 DOI: 10.1016/S0022-202X(24)02112-2
{"title":"Subscription Information","authors":"","doi":"10.1016/S0022-202X(24)02112-2","DOIUrl":"10.1016/S0022-202X(24)02112-2","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 11","pages":"Page A2"},"PeriodicalIF":5.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Snippets 临床片段
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-19 DOI: 10.1016/j.jid.2024.08.002
{"title":"Clinical Snippets","authors":"","doi":"10.1016/j.jid.2024.08.002","DOIUrl":"10.1016/j.jid.2024.08.002","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 10","pages":"Page 2109"},"PeriodicalIF":5.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subscription Information 订阅信息
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-19 DOI: 10.1016/S0022-202X(24)02007-4
{"title":"Subscription Information","authors":"","doi":"10.1016/S0022-202X(24)02007-4","DOIUrl":"10.1016/S0022-202X(24)02007-4","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 10","pages":"Page A2"},"PeriodicalIF":5.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142271513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editors’ Picks 编辑推荐
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-19 DOI: 10.1016/j.jid.2024.07.008
{"title":"Editors’ Picks","authors":"","doi":"10.1016/j.jid.2024.07.008","DOIUrl":"10.1016/j.jid.2024.07.008","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 10","pages":"Page 2110"},"PeriodicalIF":5.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of epidermal isoleucyl-tRNA synthetase ameliorates psoriasis-like skin lesions via JAK2/STAT3/CXCL16 signaling pathway. 通过 JAK2/STAT3/CXCL16 信号通路抑制表皮异亮氨酰-tRNA 合成酶可改善银屑病样皮损。
IF 6.5 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-16 DOI: 10.1016/j.jid.2024.08.021
Xi-Bei Chen,Yu-Xin Zheng,Ting-Ting Guo,Fan Xu,Ying-Zhe Cui,Lei Nie,Hai-Bin Wang,Li-Ran Ye,Ying Liu,Xing-Yu Yang,Ni-Chang Fu,Bin-Xi Yan,Min Zheng,Xiao-Yong Man
{"title":"Inhibition of epidermal isoleucyl-tRNA synthetase ameliorates psoriasis-like skin lesions via JAK2/STAT3/CXCL16 signaling pathway.","authors":"Xi-Bei Chen,Yu-Xin Zheng,Ting-Ting Guo,Fan Xu,Ying-Zhe Cui,Lei Nie,Hai-Bin Wang,Li-Ran Ye,Ying Liu,Xing-Yu Yang,Ni-Chang Fu,Bin-Xi Yan,Min Zheng,Xiao-Yong Man","doi":"10.1016/j.jid.2024.08.021","DOIUrl":"https://doi.org/10.1016/j.jid.2024.08.021","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"3 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142247567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The number of nail fold capillaries and nail fold bleedings reflects the clinical manifestations of systemic sclerosis. 甲襞毛细血管和甲襞出血的数量反映了系统性硬化症的临床表现。
IF 6.5 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-16 DOI: 10.1016/j.jid.2024.08.020
Yuta Norimatsu,Takemichi Fukasawa,Yoshinori Kabeya,Satoshi Toyama,Kazuki M Matsuda,Ai Kuzumi,Asako Yoshizaki-Ogawa,Haruka Ichimura,Sho Yonezawa,Hiroki Nakano,Shinichi Sato,Ayumi Yoshizaki
{"title":"The number of nail fold capillaries and nail fold bleedings reflects the clinical manifestations of systemic sclerosis.","authors":"Yuta Norimatsu,Takemichi Fukasawa,Yoshinori Kabeya,Satoshi Toyama,Kazuki M Matsuda,Ai Kuzumi,Asako Yoshizaki-Ogawa,Haruka Ichimura,Sho Yonezawa,Hiroki Nakano,Shinichi Sato,Ayumi Yoshizaki","doi":"10.1016/j.jid.2024.08.020","DOIUrl":"https://doi.org/10.1016/j.jid.2024.08.020","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"10 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142247616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the Dysregulating IGF-1-SP1-CD248 Pathway in Fibroblast Functionality during Diabetic Wound Healing. 解密糖尿病伤口愈合过程中成纤维细胞功能失调的 IGF-1-SP1-CD248 通路
IF 6.5 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-16 DOI: 10.1016/j.jid.2024.07.035
Ya-Chu Ku,Yao-Chou Lee,Yi-Kai Hong,Yung-Ling Lo,Cheng-Hsiang Kuo,Kuan-Chieh Wang,Chao-Kai Hsu,Chien-Hung Yu,Shu-Wha Lin,Hua-Lin Wu
{"title":"Deciphering the Dysregulating IGF-1-SP1-CD248 Pathway in Fibroblast Functionality during Diabetic Wound Healing.","authors":"Ya-Chu Ku,Yao-Chou Lee,Yi-Kai Hong,Yung-Ling Lo,Cheng-Hsiang Kuo,Kuan-Chieh Wang,Chao-Kai Hsu,Chien-Hung Yu,Shu-Wha Lin,Hua-Lin Wu","doi":"10.1016/j.jid.2024.07.035","DOIUrl":"https://doi.org/10.1016/j.jid.2024.07.035","url":null,"abstract":"Reduced fibroblast activity is a critical factor in the progression of diabetic ulcers. CD248, a transmembrane glycoprotein prominently expressed in activated fibroblasts, plays a pivotal role in wound healing. However, the role of CD248 in diabetic wound healing and the CD248 regulatory pathway remains largely unexplored. Our study shows that CD248 expression is significantly reduced in skin wounds from both diabetic patients and mice. Single-cell transcriptome data analyses reveal a marked reduction of CD248-enriched secretory-reticular fibroblasts in diabetic wounds. We identify insulin-like growth factor-1 (IGF-1) as a key regulator of CD248 expression through the Akt/mTOR signaling pathway and the Sp1 transcription factor. Overexpression of CD248 enhances fibroblast motility, elucidating the underrepresentation of CD248-enriched fibroblasts in diabetic wounds. Immunohistochemical staining of diabetic wound samples further confirm low SP1 expression and fewer CD248-positive secretory-reticular fibroblasts. Further investigation reveals that elevated tumor necrosis factor α (TNFα) levels in diabetic environment promotes IGF-1 resistance, and inhibiting IGF-1-induced CD248 expression. In summary, our findings underscore the critical role of the IGF1-SP1-CD248 axis in activating reticular fibroblasts during wound-healing processes. Targeting this axis in fibroblasts could help develop a therapeutic regimen for diabetic ulcers.","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"23 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142247612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity Scores for Cutaneous Lupus Erythematosus 皮肤红斑狼疮的严重程度评分。
IF 5.7 2区 医学
Journal of Investigative Dermatology Pub Date : 2024-09-14 DOI: 10.1016/j.jid.2024.07.032
Tyler B. Cepica , Radhika Gupta , Victoria P. Werth , Benjamin F. Chong
{"title":"Severity Scores for Cutaneous Lupus Erythematosus","authors":"Tyler B. Cepica ,&nbsp;Radhika Gupta ,&nbsp;Victoria P. Werth ,&nbsp;Benjamin F. Chong","doi":"10.1016/j.jid.2024.07.032","DOIUrl":"10.1016/j.jid.2024.07.032","url":null,"abstract":"<div><div>Despite the significant disease burden of cutaneous lupus erythematosus (CLE), there have been no United States Food and Drug Administration–approved therapies for 65 years. To facilitate advancement of therapies, severity scores are needed to evaluate QOL, how patients feel, activity of disease, and organ-specific damage to assess response to therapies and disease progression. In this paper, we delineate the development process of provider- and patient-reported severity scores for CLE. Cutaneous Lupus Disease Area and Severity Index (CLASI), a provider-reported measure that distinguishes between activity and damage, has undergone rigorous validation and reliability testing for over 20 years. Its performance has been tested in clinical trials as a primary or secondary endpoint and tool to stratify patients. As an objective disease measure that captures a provider’s perspective of disease activity and damage, the CLASI inherently does not assess disease impact on patients’ QOL. Cutaneous Lupus Erythematosus Quality of Life (CLEQoL), a patient-reported measure, captures features elucidated through focus groups, including symptoms, emotions, functioning, body image, and photosensitivity. It has undergone psychometric property testing to ensure reliability and validity. Together, CLASI and CLEQoL are simple and reliable CLE-specific severity scores capturing disease activity, damage, and QOL from provider and patient perspectives.</div></div>","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 11","pages":"Pages 2354-2363"},"PeriodicalIF":5.7,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信